oxgene
PrivateLast Round
M&A
Mar 2, 2021
Last Round Size
$135M
Est. Valuation
$135M
Total Funding Raised
$155.22M
Company Overview
The latest recorded funding round for oxgene was a Series A Extension round in March 2019. oxgene has raised $155.22M.
A UK-based contract research and development organization that designs and develops scalable technologies for the cell and gene therapy industry, now operating as a subsidiary of WuXi Advanced Therapies.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
oxgene Comparables
Compare oxgene with similar companies based on industry and business-model similarity.
No comparables are published for oxgene. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
oxgene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Mar 2, 2021 | ||||
| Series A Extension | Mar 28, 2019 | ||||
| Series A | Aug 22, 2017 | ||||
| Grant | Nov 1, 2016 | ||||
| VC Round | Oct 27, 2016 | ||||
Seed | Jul 30, 2014 |
For institutional investors. Book with your work email.
oxgene Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.